Frontlight ResearchEarly access
Trial site
Providence Saint John's Cancer Institute
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer2 trials
- Childhood cancers1 trial
- Glioblastoma1 trial
- Prostate cancer1 trial
- Phase
- Phase 32 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Completed1 trial
- Lead sponsor
- Ferring Pharmaceuticals2 trials
- Bayer1 trial
- Jazz Pharmaceuticals1 trial
- Oblato, Inc.1 trial
Running trials
Recruiting
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Recruiting
Active, not recruiting
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer2 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026